U.S. Physical Therapy, Inc. (NYSE:USPH) was the target of a significant drop in short interest in October. As of October 31st, there was short interest totalling 1,150,000 shares, a drop of 5.7% from the September 30th total of 1,220,000 shares. Based on an average daily trading volume, of 87,900 shares, the days-to-cover ratio is presently 13.1 days. Currently, 9.2% of the company’s stock are sold short.
A number of equities research analysts have weighed in on the company. Barrington Research upgraded U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price objective for the company in a research note on Friday, November 8th. ValuEngine upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Finally, Zacks Investment Research downgraded U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday. One analyst has rated the stock with a sell rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $127.20.
In related news, Director Harry S. Chapman bought 2,400 shares of the stock in a transaction dated Monday, November 11th. The stock was acquired at an average price of $117.00 per share, for a total transaction of $280,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.50% of the stock is currently owned by company insiders.
NYSE:USPH traded down $0.65 during trading hours on Monday, reaching $113.62. 54,511 shares of the stock were exchanged, compared to its average volume of 104,722. The company has a quick ratio of 1.88, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The firm has a 50 day simple moving average of $132.85 and a 200-day simple moving average of $126.64. U.S. Physical Therapy has a 52 week low of $98.69 and a 52 week high of $148.48. The stock has a market capitalization of $1.47 billion, a P/E ratio of 42.88, a P/E/G ratio of 3.29 and a beta of 1.09.
U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, November 7th. The company reported $0.71 EPS for the quarter, hitting analysts’ consensus estimates of $0.71. U.S. Physical Therapy had a return on equity of 16.57% and a net margin of 6.36%. The company had revenue of $117.30 million for the quarter, compared to the consensus estimate of $121.28 million. During the same quarter last year, the business posted $0.64 EPS. U.S. Physical Therapy’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, analysts expect that U.S. Physical Therapy will post 2.86 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 18th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.06%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 45.28%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Story: Real Estate Investment Trust (REIT) ETF
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.